Supersensitive Detection of Viral BioWarfare Agents
病毒生物战剂的超灵敏检测
基本信息
- 批准号:6643271
- 负责人:
- 金额:$ 9.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-05-01 至 2003-10-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The ability to detect biological agents across a large number of diverse locations, all of which might be targets for terrorists, is currently limited by the restricted sensitivity and non-portability of available detection systems. BioTraces, Inc. has developed a new family of MPD systems that overcome these existing limitations. MPD has several advantages over existing assay methods: better than 1,000-fold improvement in sensitivity, enabling measurement of previously undetectable amounts of target substances; concurrent measurement of multiple samples, leading to higher throughput, and the ability to perform simultaneous assays for multiple targets in a single sample using portable, light weight instruments. The proposed applications of MPD for the detection of biological warfare agents can be divided into two synergistic sub-projects: * use of a panel of MPD enhanced immunoassays for detection of viral BW agents. * development of a universal biological warfare agent detector using supersensitive P-chips/MPD. Recent events in the US have shown the vulnerability of domestic institutions to terrorist activities. Over the next few years a significant market for means of detecting and preventing terrorist attacks will develop. Because of the superior sensitivity of MPD techniques, BioTraces is in a position to capture a significant share of the detection aspect of this emerging market.
说明(由申请方提供):目前,由于现有探测系统的灵敏度有限且不便于携带,因此在许多不同地点探测生物制剂的能力受到限制,而这些地点都可能成为恐怖分子的目标。BioTraces公司已经开发了一种新的MPD系统系列,克服了这些现有的限制。与现有的检测方法相比,MPD具有几个优点:灵敏度提高了1,000倍以上,能够测量以前无法检测到的目标物质;同时测量多个样品,从而提高了通量,并能够使用便携式轻质仪器对单个样品中的多个目标进行同时检测。 将MPD用于检测生物战剂的拟议应用可分为两个协同增效的子项目:* 使用一组MPD增强免疫测定法检测病毒性生物战剂。 * 使用超灵敏P芯片/MPD开发通用生物战剂探测器。 美国最近发生的事件表明,国内机构容易受到恐怖主义活动的影响。在今后几年里,将发展一个探测和防止恐怖主义袭击手段的重要市场。由于MPD技术的上级灵敏度,BioTraces能够在这一新兴市场的检测方面占据重要份额。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andrzej K Drukier其他文献
Andrzej K Drukier的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Andrzej K Drukier', 18)}}的其他基金
Improved immunoprofiling to diagnose Alzheimer's Disease
改进免疫分析以诊断阿尔茨海默病
- 批准号:
6832129 - 财政年份:2004
- 资助金额:
$ 9.76万 - 项目类别:
Protein-Chip Diagnostic Assay Detection for Cancer
癌症的蛋白质芯片诊断分析检测
- 批准号:
6735490 - 财政年份:2004
- 资助金额:
$ 9.76万 - 项目类别:
Measuring blood markers to diagnose Alzheimer's Disease
测量血液标记物以诊断阿尔茨海默病
- 批准号:
6833336 - 财政年份:2004
- 资助金额:
$ 9.76万 - 项目类别:
Proteomic analysis during stem cell differentiation
干细胞分化过程中的蛋白质组学分析
- 批准号:
6337341 - 财政年份:2001
- 资助金额:
$ 9.76万 - 项目类别:














{{item.name}}会员




